Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP) Laura Francisco; Marta Cruz-Cañete; Carlos Pérez; José Antonio Couceiro; Enrique Otheo; Cristian Launes; Carlos Rodrigo; Ana Belén Jiménez; Marta Llorente; Abián Montesdeoca; José Rumbao; Cristina Calvo; Susana Frago; Alfredo Tagarro;

Recommendations of the Spanish Society of Neonatology for the prevention of severe respiratory syncytial virus infections with nirsevimab, for the 2023¿2024 season Manuel Sánchez Luna; Belén Fernández Colomer; M. Luz Couce Pico;

Immunisation schedule of the Spanish Association of Pediatrics: 2024 recommendations Francisco José Álvarez García; Antonio Iofrío de Arce; Javier Álvarez Aldeán; María Garcés-Sánchez; Elisa Garrote Llanos; Abián Montesdeoca Melián; Marisa Navarro Gómez; Valentín Pineda Solas; Irene Rivero Calle; Jesús Ruiz-Contreras; Pepe Serrano Marchuet;